CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,159,000 | -29.6% | 34,300 | -51.3% | 0.00% | -40.0% |
| Q1 2021 | $1,647,000 | -73.3% | 70,400 | -67.1% | 0.01% | -68.8% |
| Q4 2020 | $6,172,000 | +18.6% | 214,300 | -16.5% | 0.02% | +6.7% |
| Q3 2020 | $5,203,000 | +35.9% | 256,800 | +101.6% | 0.02% | +36.4% |
| Q2 2020 | $3,828,000 | +572.8% | 127,400 | +603.9% | 0.01% | +450.0% |
| Q1 2020 | $569,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |